Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 461

1.

Editorial.

Kosten TR, Domingo CB.

Am J Addict. 2015 Jan;24(1):1. doi: 10.1111/ajad.12212. No abstract available.

PMID:
25823625
2.

ZNF804A variants confer risk for heroin addiction and affect decision making and gray matter volume in heroin abusers.

Sun Y, Zhao LY, Wang GB, Yue WH, He Y, Shu N, Lin QX, Wang F, Li JL, Chen N, Wang HM, Kosten TR, Feng JJ, Wang J, Tang Y, Liu SX, Deng GF, Diao GH, Tan YL, Han HB, Lin L, Shi J.

Addict Biol. 2015 Feb 24. doi: 10.1111/adb.12233. [Epub ahead of print]

PMID:
25708696
3.

A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of JDTic.

Buda JJ, Carroll FI, Kosten TR, Swearingen D, Walters BB.

Neuropsychopharmacology. 2015 Jan 23. doi: 10.1038/npp.2015.27. [Epub ahead of print]

PMID:
25628006
4.

Reinforcement Sensitivity Underlying Treatment-Seeking Smokers' Affect, Smoking Reinforcement Motives, and Affective Responses.

Cui Y, Robinson JD, Engelmann JM, Lam CY, Minnix JA, Karam-Hage M, Wetter DW, Dani JA, Kosten TR, Cinciripini PM.

Psychol Addict Behav. 2015 Jan 26. [Epub ahead of print]

PMID:
25621416
5.

A conjugate vaccine attenuates morphine- and heroin-induced behavior in rats.

Li QQ, Sun CY, Luo YX, Xue YX, Meng SQ, Xu LZ, Chen N, Deng JH, Zhai HF, Kosten TR, Shi J, Lu L, Sun HQ.

Int J Neuropsychopharmacol. 2014 Dec 7;18(5). pii: pyu093. doi: 10.1093/ijnp/pyu093.

PMID:
25522425
6.

Withdrawal Symptoms and Nicotine Dependence Severity Predict Virtual Reality Craving in Cigarette-Deprived Smokers.

Thompson-Lake DG, Cooper KN, Mahoney JJ 3rd, Bordnick PS, Salas R, Kosten TR, Dani JA, De La Garza R 2nd.

Nicotine Tob Res. 2014 Dec 4. pii: ntu245. [Epub ahead of print]

PMID:
25475087
7.

Emerging drugs for the treatment of cocaine use disorder: a review of neurobiological targets and pharmacotherapy.

Shorter D, Domingo CB, Kosten TR.

Expert Opin Emerg Drugs. 2015 Mar;20(1):15-29. doi: 10.1517/14728214.2015.985203. Epub 2014 Nov 26.

PMID:
25425416
8.

Inhibitory Behavioral Control: A Stochastic Dynamic Causal Modeling Study Using Network Discovery Analysis.

Ma L, Steinberg JL, Cunningham KA, Lane SD, Kramer LA, Narayana PA, Kosten TR, Bechara A, Moeller FG.

Brain Connect. 2014 Nov 19. [Epub ahead of print]

PMID:
25336321
9.

Attenuation of cocaine-induced locomotor activity in male and female mice by active immunization.

Kosten TA, Shen XY, Kinsey BM, Kosten TR, Orson FM.

Am J Addict. 2014 Nov-Dec;23(6):604-7. doi: 10.1111/j.1521-0391.2014.12152.x. Epub 2014 Sep 22.

10.

Buprenorphine in the treatment of opioid addiction: opportunities, challenges and strategies.

Li X, Shorter D, Kosten TR.

Expert Opin Pharmacother. 2014 Oct;15(15):2263-75. doi: 10.1517/14656566.2014.955469. Epub 2014 Aug 29. Review.

PMID:
25171726
11.

Examining the utility of using genotype and functional biology in a clinical pharmacology trial: pilot testing dopamine β-hydroxylase, norepinephrine, and post-traumatic stress disorder.

Graham DP, Nielsen DA, Kosten TR, Davis LL, Hamner MB, Makotkine I, Yehuda R.

Psychiatr Genet. 2014 Aug;24(4):181-2. doi: 10.1097/YPG.0000000000000039. No abstract available.

PMID:
24983834
12.

The future potential for cocaine vaccines.

Orson FM, Wang R, Brimijoin S, Kinsey BM, Singh RA, Ramakrishnan M, Wang HY, Kosten TR.

Expert Opin Biol Ther. 2014 Sep;14(9):1271-83. doi: 10.1517/14712598.2014.920319. Epub 2014 May 16.

13.

The influence of dopamine β-hydroxylase gene polymorphism rs1611115 on levodopa/carbidopa treatment for cocaine dependence: a preliminary study.

Liu S, Green CE, Lane SD, Kosten TR, Moeller FG, Nielsen DA, Schmitz JM.

Pharmacogenet Genomics. 2014 Jul;24(7):370-3. doi: 10.1097/FPC.0000000000000055.

PMID:
24809448
14.

Hapten optimization for cocaine vaccine with improved cocaine recognition.

Ramakrishnan M, Kinsey BM, Singh RA, Kosten TR, Orson FM.

Chem Biol Drug Des. 2014 Sep;84(3):354-63. doi: 10.1111/cbdd.12326. Epub 2014 Jul 29.

PMID:
24803171
15.

Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial.

Kosten TR, Domingo CB, Shorter D, Orson F, Green C, Somoza E, Sekerka R, Levin FR, Mariani JJ, Stitzer M, Tompkins DA, Rotrosen J, Thakkar V, Smoak B, Kampman K.

Drug Alcohol Depend. 2014 Jul 1;140:42-7. doi: 10.1016/j.drugalcdep.2014.04.003. Epub 2014 Apr 16.

PMID:
24793366
16.

Epidemiological trends and the advances of treatments of amphetamine-type stimulants (ATS) in China.

Sun HQ, Chen HM, Yang FD, Lu L, Kosten TR.

Am J Addict. 2014 May-Jun;23(3):313-7. doi: 10.1111/j.1521-0391.2014.12116.x. Review.

PMID:
24724890
17.

A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study.

Spellicy CJ, Harding MJ, Hamon SC, Mahoney JJ 3rd, Reyes JA, Kosten TR, Newton TF, De La Garza R 2nd, Nielsen DA.

Genes Brain Behav. 2014 Jul;13(6):559-64. doi: 10.1111/gbb.12121. Epub 2014 Mar 17.

PMID:
24528631
18.

Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms.

Mancino MJ, McGaugh J, Chopra MP, Guise JB, Cargile C, Williams DK, Thostenson J, Kosten TR, Sanders N, Oliveto A.

J Clin Psychopharmacol. 2014 Apr;34(2):234-9. doi: 10.1097/JCP.0000000000000062.

19.

Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment.

Schottenfeld RS, Chawarski MC, Cubells JF, George TP, Lappalainen J, Kosten TR.

Drug Alcohol Depend. 2014 Mar 1;136:36-42. doi: 10.1016/j.drugalcdep.2013.12.007. Epub 2013 Dec 25.

PMID:
24462581
20.

Pharmacotherapy for stimulant-related disorders.

Haile CN, Kosten TR.

Curr Psychiatry Rep. 2013 Nov;15(11):415. doi: 10.1007/s11920-013-0415-y. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk